Evidence map›Paper›PMID 32785855›Full record

ReviewThe ultrasound journal2020

The "pandemic" increase in lung ultrasound use in response to Covid-19: can we complement computed tomography findings? A narrative review.

Luigi Vetrugno, Marco Baciarello, Elena Bignami, Andrea Bonetti, Francesco Saturno, Daniele Orso, Rossano Girometti, Lorenzo Cereser, Tiziana Bove

Abstract readReview
In one paragraph

Review in The ultrasound journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luigi VetrugnoAnesthesia and Intensive Care Clinic, Department of Medicine, University of Udine, University Hospital S. Maria della Misericordia, Udine, Italy.
Marco BaciarelloAnesthesia, Critical Care and Pain Medicine Unit, Department of Medicine and Surgery, University of Parma, Viale Gramsci, 14, 431236, Parma, Italy. marco.baciarello@unipr.it.ORCID http://orcid.org/0000-0002-6939-9764
Elena BignamiAnesthesia, Critical Care and Pain Medicine Unit, Department of Medicine and Surgery, University of Parma, Viale Gramsci, 14, 431236, Parma, Italy.
Andrea BonettiAnesthesia, Critical Care and Pain Medicine Unit, Department of Medicine and Surgery, University of Parma, Viale Gramsci, 14, 431236, Parma, Italy.
Francesco SaturnoAnesthesia, Critical Care and Pain Medicine Unit, Department of Medicine and Surgery, University of Parma, Viale Gramsci, 14, 431236, Parma, Italy.
Daniele OrsoAnesthesia and Intensive Care Clinic, Department of Medicine, University of Udine, University Hospital S. Maria della Misericordia, Udine, Italy.
Rossano GiromettiInstitute of Radiology, Department of Medicine, University of Udine, University Hospital S. Maria della Misericordia, Udine, Italy.
Lorenzo CereserInstitute of Radiology, Department of Medicine, University of Udine, University Hospital S. Maria della Misericordia, Udine, Italy.
Tiziana BoveAnesthesia and Intensive Care Clinic, Department of Medicine, University of Udine, University Hospital S. Maria della Misericordia, Udine, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease of 2019 (COVID-19) is a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has rapidly spread to a global pandemic in March 2020. This emergency condition has been putting a severe strain on healthcare systems worldwide, and a prompt, dynamic response is instrumental in its management. While a definite diagnosis is based on microbiological evidence, the relationship between lung ultrasound (LU) and high-resolution computed tomography (HRCT) in the diagnosis and management of COVID-19 is less clear. Lung ultrasound is a point-of-care imaging tool that proved to be useful in the identification and severity assessment of different pulmonary conditions, particularly in the setting of emergency and critical care patients in intensive care units; HRCT of the thorax is regarded as the mainstay of imaging evaluation of lung disorders, enabling characterization and quantification of pulmonary involvement. Aims of this review are to describe LU and chest HRCT main imaging features of COVID-19 pneumonia, and to provide state-of-the-art insights regarding the integrated role of these techniques in the clinical decision-making process of patients affected by this infectious disease.

Indexed as

COVID-19LungMultidetector computed tomographyPneumoniaRespiratory distress syndrome, adultSARS-CoV-2Severe acute respiratory syndromeUltrasonography

Identifiers

PMID32785855
PMCPMC7422672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.